Bajaj Healthcare
Bajaj Healthcare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Bajaj Healthcare
Start SIPBajaj Healthcare Investment Rating
-
Master Rating:
-
Bajaj Healthcare has an operating revenue of Rs. 716.25 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 13% is healthy, ROE of 21% is exceptional. The company has a reasonable debt to equity of 20%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 201 | 172 | 176 |
| Operating Expenses Qtr Cr | 168 | 146 | 151 |
| Operating Profit Qtr Cr | 33 | 26 | 25 |
| Depreciation Qtr Cr | 6 | 7 | 4 |
| Interest Qtr Cr | 5 | 4 | 4 |
| Tax Qtr Cr | 6 | 4 | -1 |
| Net Profit Qtr Cr | 16 | 12 | 17 |
Bajaj Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- 407.92
- 50 Day
- 409.04
- 100 Day
- 397.59
- 200 Day
- 385.44
- 20 Day
- 410.77
- 50 Day
- 418.72
- 100 Day
- 391.85
- 200 Day
- 364.97
Bajaj Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 395.22 |
| Second Resistance | 398.54 |
| Third Resistance | 401.37 |
| RSI | 33.96 |
| MFI | 37.08 |
| MACD Single Line | -4.97 |
| MACD | -7.42 |
| Support | |
|---|---|
| First Resistance | 389.07 |
| Second Resistance | 386.24 |
| Third Resistance | 382.92 |
Bajaj Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 37,331 | 1,986,383 | 53.21 |
| Week | 47,764 | 2,545,354 | 53.29 |
| 1 Month | 38,002 | 2,018,674 | 53.12 |
| 6 Month | 73,128 | 3,673,954 | 50.24 |
Bajaj Healthcare Result Highlights
Bajaj Healthcare Synopsis
NSE-Medical-Diversified
Bajaj Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 679.89 Cr. and Equity Capital is Rs. 13.80 Cr. for the Year ended 31/03/2022. Bajaj Healthcare Ltd. is a Public Limited Listed company incorporated on 15/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1993PLC072892 and registration number is 072892.| Market Cap | 1,085 |
| Sales | 716 |
| Shares in Float | 0.91 |
| No of funds | 8 |
| Yield | 0.38 |
| Book Value | 3.3 |
| U/D Vol ratio | 1.8 |
| LTDebt / Equity | 20 |
| Alpha | -0.01 |
| Beta | 0.99 |
Bajaj Healthcare
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 67.42% | 67.3% | 67.3% | |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.94% | 0.09% | 0.32% | |
| Individual Investors | 16.67% | 16.5% | 16.71% | |
| Others | 14.97% | 16.11% | 15.67% |
Bajaj Healthcare Management
| Name | Designation |
|---|---|
| Mr. Sajankumar R Bajaj | Chairman & Managing Director |
| Mr. Anil C Jain | Managing Director |
| Mr. Pakshal A Jain | Whole Time Director |
| Ms. Namrata S Bajaj | Whole Time Director |
| Mr. Dhananjay S Halte | Whole Time Director |
| Mr. Rupesh H Nikam | WholeTime Director & CFO |
| Mr. Ram B Banarase | Independent Director |
| Mr. Hemant R Karnik | Independent Director |
| Mr. Loukik D Tipnis | Independent Director |
| Mr. Avinash K Dalal | Independent Director |
| Mr. Luke B Fernandez | Independent Director |
| Ms. Kejal N Shah | Independent Director |
Bajaj Healthcare Forecast
Price Estimates
Bajaj Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-11-11 | Quarterly Results | |
| 2022-08-12 | Quarterly Results | |
| 2022-05-17 | Audited Results & Final Dividend | |
| 2022-01-28 | Quarterly Results | |
| 2021-11-02 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-09-29 | FINAL | Rs.0.50 per share(5%)Final Dividend |
| 2021-09-29 | SPECIAL | Rs.0.50 per share(5%)Special Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-09-29 | Split | Rs.0.00 split from Rs. 10/- to Rs. 5/-. |
Bajaj Healthcare FAQs
What is Share Price of Bajaj Healthcare ?
Bajaj Healthcare share price is ₹386 As on 05 February, 2023 | 15:17
What is the Market Cap of Bajaj Healthcare ?
The Market Cap of Bajaj Healthcare is ₹1066.4 Cr As on 05 February, 2023 | 15:17
What is the P/E ratio of Bajaj Healthcare ?
The P/E ratio of Bajaj Healthcare is 16.8 As on 05 February, 2023 | 15:17
What is the PB ratio of Bajaj Healthcare ?
The PB ratio of Bajaj Healthcare is 3.2 As on 05 February, 2023 | 15:17